newsfilter
← Latest News
GlobeNewswire·

Genocea to Present at the 32nd Annual Oppenheimer Healthcare Conference

CAMBRIDGE, Mass., March 14, 2022 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that Chip Clark, President and Chief Executive Officer, wil